KALVISTA PHARMACEUTICALS INC (KALV) Forecast, Price Target & Analyst Ratings

NASDAQ:KALV • US4834971032

Current stock price

19.9 USD
+0.13 (+0.66%)
At close:
19.7 USD
-0.2 (-1.01%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KALVISTA PHARMACEUTICALS INC (KALV).

Forecast Snapshot

Consensus Price Target

Price Target
$34.68
+ 74.27% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2026
EPS Estimate
-$0.32
Revenue Estimate
56.732M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$34.68
Upside
+ 74.27%
From current price of $19.90 to mean target of $34.68, Based on 15 analyst forecasts
Low
$22.22
Median
$35.70
High
$40.95

Price Target Revisions

1 Month
0.00%
3 Months
9.68%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for KALV. The average price target is 34.68 USD. This implies a price increase of 74.27% is expected in the next year compared to the current price of 19.9.
The average price target has been revised upward by 9.68% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

KALV Current Analyst RatingKALV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

KALV Historical Analyst RatingsKALV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
86.67%
KALV was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about KALV.
In the previous month the buy percentage consensus was at a similar level.
KALV was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-26CitizensMaintains Market Outperform -> Market Outperform
2026-03-26StifelMaintains Buy -> Buy
2026-03-25NeedhamMaintains Buy -> Buy
2026-01-09NeedhamMaintains Buy -> Buy
2026-01-09HC Wainwright & Co.Maintains Buy -> Buy
2026-01-06NeedhamMaintains Buy -> Buy
2025-12-04NeedhamReiterate Buy -> Buy
2025-11-11CitizensMaintains Market Outperform -> Market Outperform
2025-09-12JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-09-12NeedhamReiterate Buy -> Buy
2025-07-11HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-08JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-07-08HC Wainwright & Co.Maintains Buy -> Buy
2025-07-07Leerink PartnersMaintains Outperform -> Outperform
2025-04-08NeedhamReiterate Buy -> Buy
2025-03-26Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-03-26Jones TradingMaintains Buy -> Buy
2025-03-26NeedhamReiterate Buy -> Buy
2025-03-14HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-13NeedhamReiterate Buy -> Buy
2025-03-03Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-01-31JMP SecuritiesInitiate Market Outperform
2025-01-07TD CowenInitiate Buy
2024-12-18B of A SecuritiesInitiate Buy
2024-12-09Cantor FitzgeraldReiterate Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2026
EPS Estimate
-$0.32
Revenue Estimate
56.732M
Revenue Q2Q
N/A
EPS Q2Q
59.46%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
273.64%
Revenue (3 Months)
273.64%
EPS (1 Month)
59.87%
EPS (3 Months)
59.87%

Next Earnings Summary

The next earnings revenue estimate has been revised upward by 273.64% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
KALV revenue by date.KALV revenue by date.
49.078M211.42M
330.78%		327.56M
54.93%		420.75M
28.45%		545.24M
29.59%		630.57M
15.65%		711.33M
12.81%		785.55M
10.43%		783.36M
-0.28%
EBITDA
YoY % growth
KALV ebitda by date.KALV ebitda by date.
-110.15M
-14.68%		-139.629M
-26.76%		-111.096M
20.43%		-200.634M
-80.60%		-160.171M
20.17%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
KALV ebit by date.KALV ebit by date.
-110.87M
-14.76%		-140.445M
-26.68%		-112.037M
20.23%		-112.82M
-0.70%		-11.808M
89.53%		14.229M
220.50%		234.07M
1,545.02%		307.19M
31.24%		375.81M
22.34%		439.69M
17.00%		439M
-0.16%
Operating Margin
KALV operating margin by date.KALV operating margin by date.
N/AN/A-228.28%-53.36%-3.60%3.38%42.93%48.72%52.83%55.97%56.04%
EPS
YoY % growth
KALV eps by date.KALV eps by date.
-3.36
0.00%		-3.40
-1.19%		-1.64
51.67%		-1.80
-9.78%		0.85
147.21%		0.48
-43.71%		3.59
648.51%		4.04
12.51%		4.46
10.56%		5.16
15.49%		4.93
-4.28%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.32
59.46%		-0.04
-104.45%		-0.44
60.84%		-0.29
68.96%		-0.51
-61.29%		-0.20
-400.00%
Revenue
Q2Q % growth		56.732M65.385M39.78M
2,689.62%		53.142M
288.12%		29.272M
-48.40%		48.788M
-25.38%
EBITDA
Q2Q % growth		-20.237M
55.21%		-20.686M
-147.36%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-14.182M
69.20%		-10.157M
-123.78%		-46.098M
21.88%		-43.086M
6.44%		-33.835M
-138.57%		-13.854M
-36.40%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

KALV Yearly Revenue VS EstimatesKALV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
KALV Yearly EPS VS EstimatesKALV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 -10 -15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
31.84%
EPS Next 5 Year
34.84%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

KALVISTA PHARMACEUTICALS INC / KALV Forecast FAQ

What do analysts expect the price target to be for KALVISTA PHARMACEUTICALS INC (KALV)?

15 analysts have analysed KALV and the average price target is 34.68 USD. This implies a price increase of 74.27% is expected in the next year compared to the current price of 19.9.

What are the consensus estimates for KALV stock next earnings?

The consensus EPS estimate for the next earnings of KALVISTA PHARMACEUTICALS INC (KALV) is -0.32 USD and the consensus revenue estimate is 56.73M USD.

How do analysts rate KALVISTA PHARMACEUTICALS INC (KALV)?

The consensus rating for KALVISTA PHARMACEUTICALS INC (KALV) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.